Valley Brook Capital Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
Valley Brook Capital Group's LLY Position: Q2 2026 in Review
Valley Brook Capital Group increased its Eli Lilly (LLY) stake by 4.8% in Q2 2026, buying an estimated $76.6K and bringing the position to 1,625 shares worth $1.95M. The position accounts for 1.11% of the portfolio, ranked #27.
Valley Brook Capital Group first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. 2,854 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Valley Brook Capital Group held 1,625 shares of Eli Lilly worth $1.95M as of Q2 2026.
- Valley Brook Capital Group bought 75 Eli Lilly shares in Q2 2026, an estimated $76.6K.
- Eli Lilly made up 1.11% of Valley Brook Capital Group's portfolio in Q2 2026, its #27 holding.
- Valley Brook Capital Group first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
- 2,854 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Valley Brook Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.